The Leadership Team at Cantargia is responsible for steering the strategic direction of the company, focusing on the development of antibody-based therapies targeting the IL1RAP molecule for various cancers. This team collaborates across research, clinical development, and operational functions to ensure effective execution of the company's goals while fostering innovation and driving growth in the biopharmaceutical sector.